Midecamycin: Brief Clinico-pharmacological Review | CMAC

Midecamycin: Brief Clinico-pharmacological Review

Clinical Microbiology and Antimicrobial Chemotherapy. 2007; 9(1):66-72

Section
Type
Journal article

Abstract

Macrolides are widely used antibiotics in a variety of infections, especially community-aquired. The clinical success of macrolides is due to their activity against classical causative agents, intracellular pathogens, and some protozoa. Of great importance is their good tolerability profile, which allows their use in some «problem» categories of patients. Special attention should be paid to the representatives of 16-membered macrolides, which have certain properties making them different from other antibiotics of this class. One of them is midecamycin, that is approved for the treatment of respiratory tract infections, including diphtheria and whooping cough, skin and soft tissues infections, and genitourinary tract infections. In this review a short pharmacological description of midecamycin is presented.

Views
0 Abstract
0 PDF
0 Crossref citations
Shared